search
Back to results

Heamodynamic Effects of Paracetamol in Septic Shock Patients

Primary Purpose

Septic Shock, Sepsis

Status
Completed
Phase
Phase 4
Locations
Egypt
Study Type
Interventional
Intervention
Paracetamol
Normal saline
Sponsored by
Ayah Mohammed Khalil
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Septic Shock focused on measuring acetaminophen, paracetamol, septic shock, hemodynamic effects, blood pressure, icu

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Age adult ≥ 18 years old. The patient fulfills the criteria of septic shock definition: Sepsis needs vasopressor therapy. Serum lactate level greater than 2 mmol/l (SSC 2016). Patient with contractility greater than 40% Exclusion Criteria: paracetamol hypersensitivity or allergy. Acute liver injury or failure Childs-Pugh C liver disease Heat stroke. Malignant hyperthermia. Neuroleptic Malignant Syndrome. Continous renal replacement therapy. Ventricular assist device. Around-the-clock scheduled of acetaminophen-containing medications administration or non-steroidal anti-inflammatory drugs. Pregnancy/lactation.

Sites / Locations

  • Cairo University hospitals

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Placebo Comparator

Experimental

Experimental

Arm Label

Placebo group

bolus group

Extended infusion group

Arm Description

placebo group (100 ml normal saline over 15 minutes)

bolus group (1000mg/100 ml paracetamol over 15 minutes)

Extended infusion (1000mg/100 ml paracetamol over 3 hours)

Outcomes

Primary Outcome Measures

The incidence of hypotension .
defined as a decrease in SBP ≥ 20٪ from baseline, by extended infusion of intravenous paracetamol

Secondary Outcome Measures

The changes in hemodynamic parameters
Changes in mean arterial pressure(mmHg), diastolic blood pressure (mmHg)
The changes in hemodynamic parameters
Changes in cardiac output ( L/min)
The changes in hemodynamic parameters
Changes in heart rate (bpm)
The changes in hemodynamic parameters
Changes in central venous pressure (mmHg)
The changes in temperature
Changes in temperature (celsius)
The changes in vassopresors and fluid bolus
changes in vassopresors infusion rate (mcg/ min) and fluid bolus
The changes in vassopresors and fluid bolus
changes in fluid bolus (ml)

Full Information

First Posted
September 25, 2023
Last Updated
October 10, 2023
Sponsor
Ayah Mohammed Khalil
search

1. Study Identification

Unique Protocol Identification Number
NCT06076980
Brief Title
Heamodynamic Effects of Paracetamol in Septic Shock Patients
Official Title
Haemodynamic Effects of Paracetamol (Acetaminophen) as Extended Intravenous Infusion Versus Intravenous Bolus in Septic Shock Patients
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Completed
Study Start Date
November 1, 2020 (Actual)
Primary Completion Date
November 1, 2022 (Actual)
Study Completion Date
January 24, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Ayah Mohammed Khalil

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Sepsis is life-threatening organ dysfunction caused by a dysregulated host response to infection. Septic shock is defined as sepsis that has circulatory, cellular, and metabolic abnormalities that are associated with a greater risk of mortality than sepsis alone. Clinically, this includes patients who fulfill the criteria for sepsis who, despite adequate fluid resuscitation, require vasopressors to maintain a mean arterial pressure ≥65 mmHg and have a lactate >2 mmol/L (>18 mg/dL). Feve is a common sign of infection in septic shock critically ill patients. Many critically ill patients experience pain. Paracetamol is considered safe and currently one of the most common antipyretics and used as part of multimodal analgesia for acute pain in the intensive care unit. According to the company's product information leaflet, the rate of hypotension complicating intravenous paracetamol treatment ranges from 0.01 to 0.1%. However, recent studies reported a much higher incidence and may be harmful in critically ill adults. The hemodynamic effects of intravenous (IV) paracetamol are unknown in septic shock patients, that the most vulnerable population and hemodynamically unstable. The aim of this study is to assess the incidence of hypotension of the extended intravenous paracetamol (acetaminophen) infusion over three hours in comparing with intravenous paracetamol bolus over 15 minutes in hemodynamically unstable patients (septic shock).
Detailed Description
Sepsis, inflammatory response to infection, contributes directly or indirectly to mortality in the majority of critically ill patients. An elevated cardiac index and a decreased systemic vascular resistance leading to hypotension and hypoperfusion of vital organs characterize the early stage of septic shock. The hypotensive state is often not amenable to fluid resuscitation alone and requires institution of vasoactive agents to counter the profound fall in systemic vascular resistance, which is an integral feature of septic shock . Acetaminophen is the antipyretic and analgesic that is most often given to hospitalized patients, including those in critical care units. The mechanism of action of acetaminophen remains incompletely understood, but the antipyretic response appears to be due to blocking cyclooxygenase-II and inhibiting prostaglandin-II synthesis in the central nervous system. Intravenous (IV) acetaminophen has gained popularity for inpatient management of acute pain for its practical and clinical advantages. IV administration is associated with more predictable pharmacokinetic performance compared with rectal (30%-40% bioavailability) and oral dosage forms of acetaminophen (60%-70% bioavailability). Predictable kinetics as well as ease of IV administration has made it an especially attractive option in the critically ill patients who have altered gut absorption secondary to numerous pathophysiological and therapeutic influences . IV acetaminophen has shown promise in improving patient satisfaction, managing fever, and decreasing postoperative opioid requirements. These features have made it one of the most widely ordered medications within critical care and surgical services. Product information for IV acetaminophen lists mild effects such as nausea or vomiting among the most common adverse events (incidence ≥ 5%), with the estimated incidence of more serious adverse effects such as hypotension being <1%. However, there have been an increasing number of randomized controlled trials which indicated that the incidence of IV acetaminophen-induced hypotension may be higher than previously reported by manufacturers. These publications have prompted investigators to look more closely at the possible untoward effects of IV acetaminophen across a variety of populations. . None of these studies examined whether the extended infusion of IV paracetamol can minimize the degree of hypotension in critically heamodynamic unstable patients.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Septic Shock, Sepsis
Keywords
acetaminophen, paracetamol, septic shock, hemodynamic effects, blood pressure, icu

7. Study Design

Primary Purpose
Other
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
61 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Placebo group
Arm Type
Placebo Comparator
Arm Description
placebo group (100 ml normal saline over 15 minutes)
Arm Title
bolus group
Arm Type
Experimental
Arm Description
bolus group (1000mg/100 ml paracetamol over 15 minutes)
Arm Title
Extended infusion group
Arm Type
Experimental
Arm Description
Extended infusion (1000mg/100 ml paracetamol over 3 hours)
Intervention Type
Drug
Intervention Name(s)
Paracetamol
Other Intervention Name(s)
acetaminophen
Intervention Description
compare the hemodynamic parameters of paracetamol as bolus versus extended infusion
Intervention Type
Drug
Intervention Name(s)
Normal saline
Intervention Description
as placebo
Primary Outcome Measure Information:
Title
The incidence of hypotension .
Description
defined as a decrease in SBP ≥ 20٪ from baseline, by extended infusion of intravenous paracetamol
Time Frame
pre intervention and six hours after the intervantion
Secondary Outcome Measure Information:
Title
The changes in hemodynamic parameters
Description
Changes in mean arterial pressure(mmHg), diastolic blood pressure (mmHg)
Time Frame
pre intervention and six hours after the intervantion
Title
The changes in hemodynamic parameters
Description
Changes in cardiac output ( L/min)
Time Frame
pre intervention and six hours after the intervantion
Title
The changes in hemodynamic parameters
Description
Changes in heart rate (bpm)
Time Frame
pre intervention and six hours after the intervantion
Title
The changes in hemodynamic parameters
Description
Changes in central venous pressure (mmHg)
Time Frame
pre intervention and six hours after the intervantion
Title
The changes in temperature
Description
Changes in temperature (celsius)
Time Frame
pre intervention and six hours after the intervantion
Title
The changes in vassopresors and fluid bolus
Description
changes in vassopresors infusion rate (mcg/ min) and fluid bolus
Time Frame
pre intervention and six hours after the intervantion
Title
The changes in vassopresors and fluid bolus
Description
changes in fluid bolus (ml)
Time Frame
pre intervention and six hours after the intervantion

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age adult ≥ 18 years old. The patient fulfills the criteria of septic shock definition: Sepsis needs vasopressor therapy. Serum lactate level greater than 2 mmol/l (SSC 2016). Patient with contractility greater than 40% Exclusion Criteria: paracetamol hypersensitivity or allergy. Acute liver injury or failure Childs-Pugh C liver disease Heat stroke. Malignant hyperthermia. Neuroleptic Malignant Syndrome. Continous renal replacement therapy. Ventricular assist device. Around-the-clock scheduled of acetaminophen-containing medications administration or non-steroidal anti-inflammatory drugs. Pregnancy/lactation.
Facility Information:
Facility Name
Cairo University hospitals
City
Cairo
ZIP/Postal Code
11725
Country
Egypt

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
31046402
Citation
Maxwell EN, Johnson B, Cammilleri J, Ferreira JA. Intravenous Acetaminophen-Induced Hypotension: A Review of the Current Literature. Ann Pharmacother. 2019 Oct;53(10):1033-1041. doi: 10.1177/1060028019849716. Epub 2019 May 3.
Results Reference
background

Learn more about this trial

Heamodynamic Effects of Paracetamol in Septic Shock Patients

We'll reach out to this number within 24 hrs